-
Product Insights
Muscle Invasive Bladder Cancer (MIBC) – Drugs In Development, 2023
Global Markets Direct’s, ‘Muscle Invasive Bladder Cancer (MIBC) - Drugs In Development, 2023’, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Muscle Invasive Bladder Cancer (MIBC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Thymic Carcinoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Thymic Carcinoma - Drugs In Development, 2023’, provides an overview of the Thymic Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thymic Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Hand, Foot and Mouth Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Hand, Foot and Mouth Disease - Drugs In Development, 2023’, provides an overview of the Hand, Foot and Mouth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Generalized Anxiety Disorder (GAD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Generalized Anxiety Disorder (GAD) - Drugs In Development, 2023’, provides an overview of the Generalized Anxiety Disorder (GAD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Generalized Anxiety Disorder (GAD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Gastrointestinal Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastrointestinal Tumor - Drugs In Development, 2023’, provides an overview of the Gastrointestinal Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Thymoma (Thymic Epithelial Tumor) – Drugs In Development, 2023
Global Markets Direct’s, ‘Thymoma (Thymic Epithelial Tumor) - Drugs In Development, 2023’, provides an overview of the Thymoma (Thymic Epithelial Tumor) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thymoma (Thymic Epithelial Tumor), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Lymphocryptovirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Lymphocryptovirus Infections - Drugs In Development, 2023’, provides an overview of the Lymphocryptovirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lymphocryptovirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Atherosclerosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Atherosclerosis - Drugs In Development, 2023’, provides an overview of the Atherosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Hepatitis C – Drugs In Development, 2023
Global Markets Direct’s, ‘Hepatitis C - Drugs In Development, 2023’, provides an overview of the Hepatitis C pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...